1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, June 2017

Biopharmaceutical Analysis & Statistics, June 2017

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

1-30 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Single-use Technologies for Biopharmaceuticals: Global Markets

  • $ 6650
  • Industry report
  • June 2017
  • by BCC Research

- The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021. ...

  • Industries : Biopharmaceutical
  • Countries : World

Specialty Enzymes Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

  • $ 5795
  • Industry report
  • May 2017
  • by Transparency Market Research

Global Specialty Enzymes Market: Scope This report on specialty enzymes market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies ...

  • Industries : Biopharmaceutical
  • Countries : World

Biopharmaceutical Logistics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • May 2017
  • by Transparency Market Research

Global Biopharmaceutical Logistics Market: Overview Logistics is an essential segment of supply chain management. Logistics allows the pharmaceutical companies to establish consistency as well as efficiency ...

  • Industries : Logistics and Freight, Biopharmaceutical, Transportation
  • Countries : World

Single-use Bioprocessing Systems Market - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • April 2017
  • by Transparency Market Research

Asia Pacific Single-use Bioprocessing System Market: Overview This report on single-use bioprocessing systems market studies the current as well as future prospects of the market in Asia Pacific. The stakeholders ...

  • Industries : Biopharmaceutical
  • Countries : Asia

Agricultural Enzymes Market by Type, Product Type, Crop Type, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • May 2017
  • by MarketsandMarkets

“Agricultural Enzymes Market is projected to grow at a CAGR of 11.2% in terms of value.” The agricultural enzymes market is estimated to be valued at USD 279.2 million in 2017, and is projected to ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, Europe, North America, Asia

Depth Filtration Market by Media Type, Product, Application, Cell clarification - Global Forecast to 2022

  • $ 5650
  • Industry report
  • May 2017
  • by MarketsandMarkets

The global depth filtration market is projected to reach USD 2.96 billion by 2022 from USD 1.70 billion in 2017, at a CAGR of 11.7% from 2017 to 2022 Increasing demand for biopharmaceuticals and increasing ...

  • Industries : Biopharmaceutical
  • Countries : North America, World

High Throughput Process Development Market by Product & Service (Instrument, Software and Service), Molecule Type (Monoclonal Antibodies, Recombinant Insulin), Process (Upstream, Downstream), End User - Forecast to 2021

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The global high throughput process development market is expected to reach USD 19.78 billion in 2021 from USD 9.91 billion in 2016, at a CAGR of 14.8% from 2016 to 2021. Growth in the high throughput process ...

  • Industries : Genomics, Biotechnology
  • Countries : World, North America, Europe

Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production) and End User (Contract Manufacturing Organization) - Global Forecast to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global downstream processing market is projected to reach USD 22.03 billion by 2021 from USD 10.32 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. Increasing demand for biopharmaceuticals and ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, North America, United States

Market Access Impact (US) [Growth Hormone Deficiency]

  • $ 5440
  • Industry report
  • June 2017
  • by Firstword Pharma

What stops doctors from prescribing your brand? It may be more than one thing Market barriers affect over 20% of growth hormone prescriptions in the US, and most brands lose market share because of them. ...

  • Industries : Biopharmaceutical

Market Access Impact (EU5) [Growth Hormone Deficiency]

  • $ 5440
  • Industry report
  • June 2017
  • by Firstword Pharma

Market barriers may be costing you share, but perception could be the bigger problem Market barriers affect nearly 25% of growth hormone prescriptions in the EU5 countries. Most brands lose market share ...

  • Industries : Biopharmaceutical

Erythropoietin (EPO) Drugs Market Analysis By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application, And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • May 2017
  • by Grand View Research

The global erythropoietin (EPO) drugs market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cance ...

  • Industries : Biopharmaceutical

Biosimilars Market, Europe, Forecast to 2025

  • $ 4950
  • Industry report
  • March 2017
  • by Frost & Sullivan

A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter Patent expiration and increased use of traditional generic drugs are leading to a ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : Europe

Global Biomedical Metal Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • April 2017
  • by Accuray Research LLP

The Global Biomedical Metal Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $34.91 billion by 2025. This industry report analyzes the market estimates and ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, Asia, North America

Global Biopharmaceutical Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • April 2017
  • by Accuray Research LLP

The Global Biopharmaceutical Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $459.81 billion by 2025. This industry report analyzes the market estimates and ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : World, United States

Global Bioprocess Technology Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • April 2017
  • by Accuray Research LLP

The Global Bioprocess Technology Market is poised to grow at a CAGR of around 13.6% over the next decade to reach approximately $125.71 billion by 2025. This industry report analyzes the market estimates ...

  • Industries : Biopharmaceutical
  • Countries : World, United States

Bio Industry Markets in China

  • $ 4000
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

China’s demand for Bio Industry has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

  • Industries : Biotechnology, Biopharmaceutical, Environmental Services
  • Countries : China

Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • April 2017
  • by GlobalData

Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017" provides an overview ...

  • Industries : Medical Device, Drug Discovery and Development, Pharmaceutical, Patient Monitoring
  • Countries : United States

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • June 2017
  • by GlobalData

EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026 Summary GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland (CGF, 2003). The ...

  • Industries : Health Services, Biopharmaceutical
  • Countries : Japan, United States

Global Nanofiber Materials Market for Biomedical Industry 2017-2021

  • $ 3500
  • Industry report
  • May 2017
  • by Infiniti Research Limited

About Nanofibers Materials Nanomaterials, along with advancements in nanotechnology, have the potential to revolutionize existing industries and create entirely new applications. In the last decade, nanotechnology ...

  • Industries : Advanced Material, Textile, Nanotechnology, Biopharmaceutical
  • Countries : World

Global Single-use Bioprocessing System Market 2017-2021

  • $ 3500
  • Industry report
  • April 2017
  • by Infiniti Research Limited

About Single-Use Bioprocessing System The single-use bioprocessing systems market is rapidly evolving. It focuses on developing disposable bioprocessing equipment and accessories for manufacturing of ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World

Global Digestive Enzyme Supplements Market 2017-2021

  • $ 3500
  • Industry report
  • April 2017
  • by Infiniti Research Limited

About Digestive Enzyme Supplements Digestive enzymes are substances produced by a human body that aid in digestion of food. In cases of individuals, where there are insufficient enzymes, digestive enzyme ...

  • Industries : Healthcare
  • Countries : World

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2017 Summary Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2017 Summary According to the recently published report 'T Cell Surface Glycoprotein CD4 - Pipeline Review, ...

  • Industries : Therapy, Pathology
  • Countries : United States, World

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H1 2017 Summary T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - CD28 is a proteins expressed on T cells. It co-stimulates ...

  • Industries : Therapy, Biological Therapy, Drug Discovery and Development, Pathology
  • Countries : World, United States

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Biotechnology, Biological Therapy
  • Countries : United States, World

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2017 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 14 molecules. Out of which approximately 10 molecules are ...

  • Industries : Pathology, Cancer
  • Countries : World, United States

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H1 2017 Summary According to the recently published report 'Integrin Beta ...

  • Industries : Therapy, Health Services, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : World, United States

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H1 2017 Summary Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an important ...

  • Industries : Pathology, Therapy
  • Countries : United States

Top 50 Companies in Point-of-Care Diagnostic Testing

  • $ 3500
  • Industry report
  • May 2017
  • by Kalorama Information

The POC market is considered evolving with growthopportunity.   Developing and developedmarkets alike have room to grow due to an aging population worldwide.  Key companies such as Roche, LifeScan,Abbott, ...

  • Industries : Diagnostics
  • Countries : World

Global Personalized Medicine Partnering 2010 - 2017: Deal trends, players, financials and forecasts

  • $ 3495
  • Industry report
  • April 2017
  • by Currentpartnering

The Global Personalized Medicine Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the ...

  • Industries : Biopharmaceutical
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.